ACTIVE HALF-LIFE
16 hours
CLASSIFICATION
Anabolic Steroid
DOSAGE
Men 25-50 mg/day
ACNE
Yes
WATER RETENTION
Low
HBR
Perhaps
HEPATOTOXICITY
Yes
AROMATIZATION
No
MANUFACTURER
Euro-Pharmacies - US
LAB TEST
See Document
WAREHOUSE
USA Warehouse 3
SUBSTANCE
Chlorodehydro Methyltest
,
Turaxel's active ingredient is Chlorodehydromethyltestosterone, which has a structure closely resembling Methandrostenolone.
This compound possesses weak androgenic activity, only 50% of that of testosterone, while its anabolic effects reach 180%. Turaxel doesn’t convert to estrogens and therefore doesn’t lead to side effects like fluid retention, hypertension, or gynecomastia. Furthermore, Turanabol has minimal impact on suppressing natural testosterone levels. As a result, Turanabol can be regarded as one of the safest anabolic steroids currently available.
Effects of the drug include:
Possible side effects:
Since Turaxel does not convert to estrogen, it does not cause estrogen-related side effects, such as gynecomastia, high blood pressure, or water retention. Athletes can quickly gain high-quality muscle mass with this anabolic steroid, but it is essential not to exceed the recommended dosage.
Turaxel Cycles:
While strength gains and muscle mass increases may not be rapid when using Turanabol, the end outcomes tend to be impressive. This substance reduces levels of SHBG and boosts free testosterone. Typical dosages start at about 30 mg daily, divided into three equal doses. It is common for daily doses to reach 50-60 mg. A cycle should last at least 5-6 weeks.
The drug is versatile, suitable for both bulking and cutting cycles, and does not necessitate the use of anti-estrogens during the cycle. A solo Turanabol cycle is appropriate for athletes with sufficient body weight; otherwise, combining it with other anabolic steroids is advisable.
For muscle mass gain, Turaxel is best paired with:
This combination often yields better results than using the drugs independently, with the combination of Turanabol and Deca being particularly effective.